Evolent Health, Inc.: Boehler Adam amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Evolent Health Inc. shareholder Boehler Adam filed an amended Schedule 13G with the SEC (accession 0000950103-26-017513), updating his previously reported beneficial ownership position in the healthcare company. The filing, submitted under the short-form 13G regime used by passive and institutional investors, revises the stake disclosure rather than signaling an activist campaign. The amendment matters because 13G updates can reveal shifts in ownership concentration among large holders, which investors track for governance and liquidity signals. Details of the exact share count and percentage change were not specified in the headline disclosure. What to watch next: the full filing text for updated share totals and any indication of whether the position was increased, trimmed, or left unchanged.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Boehler Adam, Evolent Health, Inc.